Comparing two thyroid hormone treatments for advanced thyroid cancer
Treatments studied
Part of Cancer, Hormones & metabolism clinical trials.
This study compares two ways of suppressing a hormone that can make thyroid cancer grow. It aims to find which method is better for people with advanced thyroid cancer that cannot be removed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with differentiated thyroid cancer (papillary, follicular, oncocytic, or poorly differentiated) that has spread or cannot be removed with surgery.
- You live in Alberta and are being treated at the Cross Cancer Institute in Edmonton.
- You are able to provide a tissue sample for genetic testing (from a previous biopsy or surgery).
- If you can become pregnant, you agree to use highly effective birth control during the study and for 30 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
This study looks at how well different second-line medicines work for people with a type of thyroid cancer that no longer responds to radioactive iodine. It is an observational study, so you continue your regular treatment and the researchers just collect information about your experience.
This trial tests whether combining two thyroid hormone medications (levothyroxine and desiccated thyroid extract) can better keep your TSH in the target range after thyroid cancer surgery. The goal is to reduce the chance of the cancer coming back while managing side effects.
This study tests if a man-made hormone (rhTSH) can make radioactive iodine therapy more effective for people with advanced thyroid cancer that has come back or spread. It aims to see if it helps find and treat cancer that doesn't respond well to standard radioactive iodine.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This trial compares a targeted therapy pill combination (dabrafenib and trametinib) with cabozantinib or chemotherapy for people with a specific type of advanced thyroid cancer (differentiated thyroid cancer) that has a BRAF V600E mutation. It aims to find which treatment works better after previous treatments have stopped working.
Hear when a new Advanced Differentiated Thyroid Gland Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.